Trials / Recruiting
RecruitingNCT06392217
clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases
Real-world Study of Incadronate in Breast Cancer Patients With Metastatic Bone Disease: clinIcal Efficacy and Safety
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a real-world study to explore the efficacy and safety of incadronate in the treatment of breast cancer patients with bone metastases.
Conditions
Timeline
- Start date
- 2024-03-12
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2024-04-30
- Last updated
- 2024-04-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06392217. Inclusion in this directory is not an endorsement.